Status:
RECRUITING
Increasing Access to Fertility Preservation for Women with Breast Cancer
Lead Sponsor:
University Paul Sabatier of Toulouse
Collaborating Sponsors:
National Cancer Institute, France
Institut Claudius Regaud
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
The EVAPREF project aims to increase access to fertility preservation by developing an approach to improve and evaluate existing information and coordination tools developed by the Pays-de-la-Loire an...
Detailed Description
Background: With the increase in the number of long-term survivors, interest is shifting from cancer survival to life and quality of life after cancer. These include consequences of long-term side ef...
Eligibility Criteria
Inclusion
- Patients over 18 and under 40 years of age treated for newly diagnosed breast cancer and receiving chemotherapy.
- People who are able to read the study information poster and the fertility preservation information brochure in French, either alone or with help from a caregiver or relative or an interpreter.
- People with intellectual disability will be included as long as they are able able to read the study information poster and the fertility preservation information brochure in French alone or with help from a caregiver or relative or an interpreter..
Exclusion
- People whose mental health status precludes participation in the study, as determined by the clinical team.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT05989776
Start Date
June 1 2022
End Date
December 1 2026
Last Update
December 12 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Nantes
Nantes, France
2
Institut Claudius Regaud (IUCT-O)
Toulouse, France